Loading: 100%
Mallinckrodt plc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker MNKno data available
Financial year endsFY ends End of Septemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17020406080
datesClosing price (adj.)
13.10.201733.29
11.10.201735.69
04.10.201737.36
27.09.201735.39
20.09.201734.49
13.09.201735.64
06.09.201736.28
30.08.201739.37
23.08.201737.21
16.08.201735.94
09.08.201737.72
02.08.201743.57
26.07.201746.43
19.07.201744.87
12.07.201744.10
05.07.201745.22
27.06.201744.89
20.06.201743.31
13.06.201743.16
06.06.201740.08
30.05.201743.67
23.05.201739.86
16.05.201744.83
09.05.201744.55
02.05.201746.84
25.04.201745.90
18.04.201743.85
11.04.201743.62
04.04.201743.90
28.03.201744.33
21.03.201744.05
14.03.201747.98
07.03.201749.71
28.02.201752.42
21.02.201754.11
14.02.201751.14
07.02.201750.23
31.01.201748.73
24.01.201746.21
17.01.201749.42
10.01.201753.75
03.01.201751.73
27.12.201651.77
19.12.201653.38
12.12.201652.04
05.12.201653.56
28.11.201657.67
21.11.201656.86
14.11.201667.88
07.11.201656.91
31.10.201659.26
24.10.201661.67
17.10.201664.96
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
33.29n/a
Market Capitalisation
in million USD
3,307n/a
Enterprise Value
in million USD
9,072n/a
Common Shares Outstanding
as per May 1, 2017
99,346,584n/a
Preferred Shares Outstanding
as per May 1, 2017
n/a
Average Basic Shares Outstanding
TTM
107,575,000n/a
Average Diluted Shares Outstanding
TTM
108,325,000n/a
Index Membership
n/a
Business Summary
Mallinckrodt PLC is a drug manufacturing company that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products. It operates in two segments including branded pharmaceuticals and generic drugs.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 3,381n/a
Gross Profit 1,855n/a
Operating Income 668n/a
EBITDA 1,502n/a
Net Profit 644n/a
Balance Sheet
Cash and Cash Equivalents 281n/a
Receivables 466n/a
Total Current Assets 1,507n/a
PP&E 844n/a
Total Assets 15,499n/a
Accounts Payable 110n/a
Current Debt 256n/a
Total Current Liabilities 1,235n/a
Long-Term Debt 5,789n/a
Total Liabilities 10,228n/a
Total Equity 5,271n/a
Cash Flow
Depreciation & Amortisation 835n/a
Change in Working Capital 116n/a
Operating Cash Flow 1,185n/a
Net Change in PP&E and Intangibles -183n/a
Investing Cash Flow -108n/a
Dividends Paid 0n/a
Financing Cash Flow -1,162n/a
Total Change in Cash -85n/a
Free Cash Flow 1,691n/a
Profitability Ratios
Gross Margin 54.9%n/a
Operating Margin 19.7%n/a
Net Profit Margin 19.0%n/a
Return on Equity 12.2%n/a
Return on Assets 4.2%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 6.04n/a
EV/Sales 2.68n/a
Book to Market Value 1.59n/a
Other Ratios
Current Ratio 122.0%n/a
Liabilities to Equity Ratio 194.0%n/a
Debt to Assets Ratio 39.0%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
2,022
2,056
1,712
1,650
2,923
3,381
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
-1,107
-1,091
-890
-766
-1,300
-1,526
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
915
965
822
885
1,623
1,855
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-674
-696
-654
-752
-1,227
-1,188
Selling, General & Administrative
-533
-552
-496
-611
-1,024
-925
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
-142
-144
-158
-141
-203
-262
Depreciation & Amortization
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
241
269
169
133
396
668
Non-Operating Income (Loss)
3
1
-18
-78
-247
-384
Interest Expense, net
0
0
-19
-81
-255
-383
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
3
1
1
3
8
-1
Pretax Income (Loss), Adjusted
243
270
151
55
149
284
Abnormal Gains (Losses)
0
-34
-95
-90
-42
-50
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
243
236
56
-35
107
233
Income Tax (Expense) Benefit, net
-86
-95
-48
13
129
256
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
157
141
8
-22
237
489
Net Extraordinary Gains (Losses)
-6
-7
51
-297
88
155
Discontinued Operations
-6
-7
51
-297
88
155
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
151
135
59
-319
325
644
Minority Interest
0
0
0
0
0
0
Net Income
151
135
59
-319
325
644
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
151
135
59
-319
325
644
Remarks
restated on Dec 13, 2013 n/a
calculated values,
restated on Nov 25, 2014 n/a
calculated values,
restated on Nov 24, 2015 n/a
calculated values,
restated on Nov 29, 2016 n/a
calculated values,
restated on Nov 29, 2016 n/a
calculated values,
restated on Nov 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
0
276
708
366
281
Cash & Cash Equivalents
n/a
0
276
708
366
281
Short Term Investments
n/a
0
0
0
0
0
Accounts & Notes Receivable
n/a
315
401
477
490
466
Accounts Receivable, Net
n/a
315
401
477
490
466
Notes Receivable, Net
n/a
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
Inventories
n/a
435
403
306
262
336
Raw Materials
n/a
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
Other Short Term Assets
n/a
151
306
580
729
425
Prepaid Expenses
n/a
31
134
227
194
116
Derivative & Hedging Assets
n/a
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
201
395
309
Deferred Tax Assets
n/a
120
171
152
139
0
Income Taxes Receivable
n/a
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
Total Current Assets
n/a
902
1,385
2,071
1,846
1,507
Property, Plant & Equipment, Net
n/a
945
997
887
793
844
Property, Plant & Equipment
n/a
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
Other Long Term Assets
n/a
1,052
1,174
9,830
13,765
13,148
Intangible Assets
n/a
366
422
7,082
9,666
9,182
Goodwill
n/a
508
532
2,402
3,649
3,705
Other Intangible Assets
n/a
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
179
220
345
449
261
Total Noncurrent Assets
n/a
1,997
2,172
10,716
14,558
13,992
Total Assets
n/a
2,899
3,557
12,787
16,404
15,499
Liabilities and owners' equity
Payables & Accruals
n/a
197 197100000
235 235200000
295 294700000
292 292000000
307 306700000
Accounts Payable
n/a
113 112500000
121 120900000
111 110700000
117 116800000
110 110100000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
85 84600000
114 114300000
184 184000000
175 175200000
197 196600000
Short Term Debt
n/a
1 1300000
2 1500000
21 21200000
22 22000000
256 256300000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
222 221700000
364 363500000
589 588900000
615 615400000
672 671700000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
222 221700000
364 363500000
589 588900000
615 615400000
672 671700000
Total Current Liabilities
n/a
420 420100000
600 600200000
905 904800000
929 929400000
1,235 1234700000
Long Term Debt
n/a
9 8900000
918 918300000
3,874 3874000000
6,474 6474300000
5,789 5788700000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
2,385 2385000000
783 782500000
3,051 3050500000
3,689 3689200000
3,205 3204600000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
190 189600000
108 108000000
116 116200000
114 114200000
145 144900000
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
93 93100000
463 463200000
2,522 2522200000
3,239 3238800000
2,649 2649100000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
2,102 2102300000
211 211300000
412 412100000
336 336200000
411 410600000
Total Noncurrent Liabilities
n/a
2,394 2393900000
1,701 1700800000
6,925 6924500000
10,164 10163500000
8,993 8993300000
Total Liabilities
n/a
2,814 2814000000
2,301 2301000000
7,829 7829300000
11,093 11092900000
10,228 10228000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
0 0
1,114 1113600000
5,196 5195600000
5,381 5381100000
5,436 5436300000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
-18 -17500000
-110 -109700000
-763 -762600000
Retained Earnings
n/a
0 0
34 33500000
-286 -285800000
39 38900000
683 682600000
Other Equity
n/a
85 84900000
109 108500000
66 65700000
1 900000
-86 -85600000
Equity Before Minority Interest
n/a
85 84900000
1,256 1255600000
4,958 4958000000
5,311 5311200000
5,271 5270700000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
85 84900000
1,256 1255600000
4,958 4958000000
5,311 5311200000
5,271 5270700000
Total Liabilities & Equity
n/a
2,899 2898900000
3,557 3556600000
12,787 12787300000
16,404 16404100000
15,499 15498700000
Remarks restated on n/a restated on Dec 13, 2013 n/a restated on Nov 25, 2014 n/a restated on Nov 24, 2015 n/a restated on Nov 29, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
157
141
59
-319
325
644
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
120
131
140
276
673
835
Non-Cash Items
35
9
17
350
-134
-410
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
58
-25
-79
67
33
116
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
370
256
136
373
896
1,185
Change in Fixed Assets & Intangibles
-120
-144
-148
-128
-148
-183
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
-13
-88
-2,794
-2,155
22
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
8
5
1
31
6
53
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
-113
-152
-235
-2,891
-2,297
-108
Dividends Paid
0
0
0
0
0
0
Cash From (Repayment of) Debt
-1
-1
897
3,008
1,162
-470
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
1
8
-58
-639
Increase in Capital Stock
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
Other Financing Activities
-256
-102
-524
-63
-34
-53
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
-258
-104
373
2,954
1,070
-1,162
Net Cash Before Disc. Operations and FX
0
0
274
437
-330
-86
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
0
0
274
437
-330
-86
Effect of Foreign Exchange Rates
0
0
1
-4
-12
0
Net Changes in Cash
0
0
276
432
-342
-85
Remarks
restated on Dec 13, 2013 n/a
calculated values,
restated on Nov 25, 2014 n/a
calculated values,
restated on Nov 24, 2015 n/a
calculated values,
restated on Nov 29, 2016 n/a
calculated values,
restated on Nov 29, 2016 n/a
calculated values,
restated on Nov 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo